<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://peptide.zone/story/cagrisema-redefine-9-lower-doses</loc><news:news><news:publication><news:name>Peptide Zone</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T18:25:00.000Z</news:publication_date><news:title>CagriSema REDEFINE 9 lower doses cut weight by about 21 percent in Phase 3 trial</news:title></news:news></url>
  <url><loc>https://peptide.zone/story/mounjaro-health-canada-heart-indication</loc><news:news><news:publication><news:name>Peptide Zone</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T18:03:00.000Z</news:publication_date><news:title>Mounjaro Health Canada approval adds heart risk indication in type 2 diabetes</news:title></news:news></url>
  <url><loc>https://peptide.zone/story/tirzepatide-hfpef-summit-cardiac-mri</loc><news:news><news:publication><news:name>Peptide Zone</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T17:22:00.000Z</news:publication_date><news:title>Tirzepatide HFpEF imaging substudy finds smaller atria and right ventricle in SUMMIT</news:title></news:news></url>
  <url><loc>https://peptide.zone/story/stopping-glp-1-drugs-heart-events-italy</loc><news:news><news:publication><news:name>Peptide Zone</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T16:36:00.000Z</news:publication_date><news:title>Stopping GLP 1 drugs tracks with twice the heart event rate in Italian diabetes cohort</news:title></news:news></url>
  <url><loc>https://peptide.zone/story/glp-1-prediabetes-metformin-aha</loc><news:news><news:publication><news:name>Peptide Zone</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T16:09:00.000Z</news:publication_date><news:title>GLP 1 drugs in prediabetes tied to less diabetes and fewer heart events than metformin</news:title></news:news></url>
</urlset>